Stocks to watch today on January 18: HCL Tech, InterGlobe Aviation, SpiceJet, Vedanta, Wipro, DHFL, JBM Auto among others are the top stocks to watch out for in Monday s trading session
HDFC Bank reported 18.1% rise in net profit to Rs 8,758.29 crore on 4.1% increase in total income to Rs 37,522.92 crore in Q3 FY21 over Q3 FY20. Net interest income for the quarter ended 31 December 2020 grew by 15.1% to 16,317.6 crore from 14,172.9 crore for the quarter ended 31 December 2019, driven by advances growth of 15.6%, and a core net interest margin for the quarter of 4.2%.
HDFC Bank said that the impact of COVID-19, including changes in customer behaviour and pandemic fears, as well as restrictions on business and individual activities, has led to significant volatility in global and Indian financial markets and a significant decrease in global and local economic activity, which may persist. While there has been a gradual pickup in economic activity since the easing of lockdown measures, the continued slowdown led to a decrease in loan originations, the sale of third-party products, the use of credit and debit cards by customers and the efficiency in collection efforts.
An Indian startup ecosystem of the youth, for the youth, by the youth
At the Prarambh: Startup India International Summit, Prime Minister Narendra Modi announced the launch of Rs 1,000-crore Startup India Seed Fund to support startups and help budding entrepreneurs pursue innovative ideas.
0 claps
Good morning!
If you re a young startup (and a very early stage one at that), you have good reason to cheer!
“We are trying to create a startup ecosystem that is based on the principle ‘of the youth, by the youth, for the youth,” emphasised PM Modi.
Prime Minister Narendra Modi
He lauded startups for powering India’s drive to be self-reliant amidst the COVID-19 pandemic. Startups, Modi said, are changing the very “demographic character of business.”
Earlier, the independent Data and Safety Monitoring Board (DSMB) had reviewed the safety data from the Phase 2 clinical trial of the vaccine and recommended it for Phase 3 clinical trial.
Dr Reddy s Sputnik Vaccine Gears Up for Phase 3 Clinical Trial, Gets DCGI Nod
The phase 3 study of Sputnik V will be conducted on 1,500 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study
| 16 Jan 2021 7:20 AM GMT
NEW DELHI: Hyderabad based, Dr Reddy s Laboratories announced that the Drugs Control General of India (DCGI) has given them the nod to conduct phase 3 clinical trial for the Sputnik V vaccine.
Earlier, GV Prasad, Co-chairman & MD of Dr Reddy s Laboratories said, The phase 2 study in India conducted by Dr Reddy s & RDIF showed a very good safety profile. The further reinforces our confidence in the safety of Sputnik V, which has now been administered to more than 1 million people in Russia & 3000,000 people in Argentina. We are working towards fast-tracking the launch of the Sputnik V vaccine in India.